Private equity eyes $13 billion Bayer plastics business, say sources-Reuters
Private equity firms are circling Bayer's (BAYGn.DE) 10 billion-euro ($12.7 billion) plastics business, hoping to divert the German drugmaker from its plan to list the division, sources told Reuters.





